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Introduction
Parkinson’s disease is a chronic neurodegenerative condition 
that leads to progressive disability (Poewe and Mahlknecht 
2009), reduced health-related quality of life, and high 
healthcare costs (Weintraub et al 2008, Kaltenboeck et 
al 2011). It is expected that more than 8 million people 
worldwide may develop Parkinson’s disease in the coming 
decades (Dorsey et al 2007).
The clinical hallmarks of Parkinson’s disease include 
bradykinesia, postural instability, pathological tremor 
(5–6 Hz), and stiffness in the limbs and trunk (Kwakkel 
et al 2007). In addition, several studies have provided 
evidence that people with Parkinson’s disease have reduced 
muscle strength compared to age-matched controls (Allen 
et al 2009, Cano-de-la-Cuerda et al 2010, Inkster et al 
2003, Nallegowda et al 2004). The dopaminergic deﬁcit 
in Parkinson’s disease causes reduction in the excitatory 
drive of the motor cortex (Lang and Lozano 1998), which 
can affect motor unit recruitment and results in muscle 
weakness (David et al 2012). Correlation studies have 
demonstrated that muscle strength is related to measures 
of physical performance such as sit-to-stand (Inkster et 
al 2003, Pääsuke et al 2004) and gait (Nallegowda et al 
2004), and to risk of falls (Latt et al 2009) in people with 
Parkinson’s disease.
Progressive resistance exercise has been suggested as a 
treatment option to preserve function and health-related 
quality of life in Parkinson’s disease (David et al 2012, 
Dibble et al 2009, Falvo et al 2008). Consequently, some 
studies have reported increases in strength after progressive 
resistance exercise training in patients with Parkinson’s 
disease, and that increased strength can translate into 
improved measures of physical performance such as gait 
(6-minute walk and gait velocity), stair-climbing and Timed 
Up and Go test (Dibble et al 2006, Dibble et al 2009). On 
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What is already known on this topic: Parkinson’s 
disease causes tremor and reduces mobility and 
functional performance. People with Parkinson’s 
disease also have reduced strength compared to  
age-matched controls. Progressive resistance 
exercise improves strength but it is unclear how large 
this effect is and whether functional performance is 
also improved.
What this study adds: Progressive resistance 
exercise has a moderate effect on strength in people 
with Parkinson’s disease. Some measures of mobility 
and functional performance also improve, including 
walking capacity and sit-to-stand time. However, this 
evidence is derived mainly from trials involving people 
with Parkinson’s disease of mild or moderate severity.
. Open access under CC BY-NC-ND license.
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the other hand, a recent study has reported improvements in 
muscle strength without carryover to gait (6-minute walk), 
mobility (Timed Up and Go test) and balance (Activities-
speciﬁc Balance Conﬁdence scale) (Schilling et al 2010).
Recent reviews established a rationale for the use of 
resistance training and highlight ﬁndings related to positive 
effects of progressive resistance exercise in people with 
Parkinson’s disease. However, meta-analysis was not 
performed, limiting the conclusions about these effects in 
such patients (Falvo et al 2008, David et al 2012).
Progressive resistance exercise will only be widely 
implemented in clinical practice as a therapy for Parkinson’s 
disease if it is found to be effective and worthwhile in terms 
of improvements in physical performance. Therefore, the 
research questions of this systematic review were:
1. Does progressive resistance exercise increase muscle 
strength in people with Parkinson’s disease?
2. Does progressive resistance exercise improve 
functional measures of physical performance?
Method
Identiﬁcation and selection of trials
Searches of CINAHL (1982 to November 2011), PEDro 
(to November 2011), LILACS (to November 2011), and 
MEDLINE databases were conducted without language 
restrictions. Searches were performed using terms 
recommended by the Cochrane Collaboration related to 
Parkinson’s disease and randomised or quasi-randomised 
controlled trials and words related to progressive resistance 
training (see Appendix 1, available on the eAddenda). Titles 
and abstracts (where available) were displayed and screened 
by a single reviewer to identify potentially relevant trials. 
Full text copies of potentially relevant trials were retrieved 
and their reference lists were screened. The retrieved 
papers were assessed for eligibility by two independent 
researchers blinded to authors, journal, and outcomes, 
using predetermined criteria (Box 1). Disagreements were 
resolved by discussion with a third reviewer.
Assessment of characteristics of trials
Quality: The quality of included trials was assessed 
by extracting scores from the Physiotherapy Evidence 
Database (PEDro) website. Rating of trials in PEDro 
is carried out by two trained independent raters, with 
disagreements resolved by a third rater. The PEDro scale 
assesses the methodological quality and statistical reporting 
of a randomised trial against 11 individual criteria (Maher 
et al 2003). One item relates to external validity and the 
remaining 10 items can be tallied to give a score from 0 to 
10 (de Morton 2009). 
Participants: Trials involving patients with Parkinson’s 
disease, regardless of gender or level of disability, were 
eligible. Age, gender, and severity of the disease was 
recorded using the Hoehn and Yahr Scale, where reported.
Intervention: The experimental intervention had to be 
progressive resistance exercise, deﬁned as movement 
against progressively increased resistance. It had to be of a 
dose that could be expected to improve strength, ie, it had to 
involve repetitive, strong, or effortful muscle contractions, 
and it had to be stated or implied that the intensity was 
progressed as ability changed.
Outcome measures: Continuous measures of muscle 
strength (eg, force, torque, work, EMG) and physical 
performance (sit-to-stand time, fast and comfortable 
walking speeds, 6-min walk test, stair descent and ascent, 
the Activities-speciﬁc Balance Conﬁdence scale, Timed Up 
and Go test, and the Short Physical Performance Battery) 
were used in the analysis where available. Otherwise, 
ordinal measures of strength (eg, Manual Muscle Test) were 
used. When both limbs were trained, the most affected limb 
was used in the analysis.
Data analysis
Data were extracted from the included trials by a single 
reviewer and cross-checked by a second reviewer. 
Information about the method (design, participants, 
intervention, and measurements) and outcome data (number 
of participants and mean and standard deviations of strength 
and measures of physical performance) were extracted. 
Where information was not available in the published 
trials, details were requested from the author listed for 
correspondence.
All trials reported pre-and post-intervention scores. Post-
intervention scores were used in the meta-analysis. When 
the same methods of measurement were used, the effect 
size was reported as a weighted mean difference with a 95% 
CI. When different methods were used, the effect size was 
reported as Cohen’s standardised mean difference with a 
95% CI. After conﬁrmation of low heterogeneity with the 
I2 statistic, the analyses were performed using The MIX–
Meta-Analysis Made Easy program (Bax et al 2006, Bax et 
al 2008) and pooled estimates were obtained using a ﬁxed 
effects model.
#PY. Inclusion criteria.
Research design
t Randomised controlled trial, or quasi-randomised 
controlled trial
Participants
t Patients with Parkinson’s disease (any level of 
TFWFSJUZo)PFIO:BIS

t No surgery
Interventions
t Progressive resistance exercise
t Repetitive effortful muscle contractions
Outcomes 
t Measure of muscle strength (voluntary force 
production)
t Measure of physical performance (sit-to-stand time, 
fast and comfortable walking speeds, 6-min walk 
test, stair ascent and descent, the Activities-speciﬁc 
Balance Conﬁdence scale, Timed Up and Go test, 
and the Short Physical Performance Battery)
Comparisons
t Progressive resistance exercise versus no 
JOUFSWFOUJPOQMBDFCP
t Progressive resistance exercise plus other therapy 
versus other therapy
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Results
Flow of trials through the review
The search strategy identiﬁed 339 papers. After screening 
titles and abstracts, 8 full papers were retrieved. After 
assessment against the inclusion criteria, 2 randomised 
trials (Allen et al 2010a, Hirsch et al 2003) and 2 quasi-
randomised trials (Dibble et al 2006, Schilling et al 2010) 
were included in the review. Figure 1 shows the trial 
selection process.
Characteristics of included trials
Quality: The mean PEDro score of the trials was 5 (Table 
1). Two trials were randomised trials that had mean PEDro 
scores of 8 and 5. True randomisation was carried out in 
50% of trials, and concealed allocation, assessor blinding, 
and intention-to-treat analysis in 25%. No trials blinded 
participants or therapists, which would have been difﬁcult 
due to the type of intervention.
Participants: The four trials included 92 people with 
Parkinson’s disease. The mean age of participants across 
trials ranged from 57 to 75.7 years. The severity of the 
disease ranged from 1.8 to 2.5 on the Hoehn and Yahr 
scale. Only three trials reported the Hoehn and Yahr scores 
(Hirsch et al 2003, Dibble et al 2006, Schilling et al 2010) 
and only 2 trials reported gender.
Intervention: The trials examined three short-term 
interventions that ranged from 2 to 3 months (Schilling et al 
Titles and abstracts screened 
(n = 339)
Potentially relevant papers 
retrieved for evaluation of full text 
(n = 8)
Papers included in systematic 
review (n = 4)
Papers excluded after 
evaluation of full text (n =4)
t No control group (n = 1)
t Same participants reported 
in other study (n = 2)
t Comparison with alternative 
intervention (n = 1)
Papers excluded after 
TDSFFOJOHUJUMFTBCTUSBDUT 
(n = 331)
'JHVSF. Identiﬁcation and selection of trials.
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5BCMF. Summary of included trials (n = 4).
Trial Design Participants Interventiona Outcome measures
Allen et al 
(2010a)
RCT n = 45
Age (yr) = Exp 66 (SD 
10); Con 68 (SD 7)
HY = not reported
Exp =  Balance exercise + PRE (standing up and sitting 
down, heel raises in standing, half squats and forward 
or lateral step-ups onto a block) + Falls prevention 
advice (booklet)
  Progression: Initial exercise session: weighted vests 
0% or up to 2% of their body weight added to the 
vest. Subsequent session: the weight in the vest was 
increased until 15 (hard or heavy) on Borg rating of 
perceived exertion.
 XFFLÛXFFLToNJO
Con = Usual care + Falls prevention advice (booklet)
Muscle strength
Knee E (strain gauge, kg)
Physical performance
Sit to stand time (5 reps) (s)
Fast walking speed (m/s)
Comfortable walking speed (m/s)
SPPB (score)
Follow-up = 0, 24 weeks
Dibble et 
al (2006)
Q-RCT n = 19
Age (yr) = Exp 64 (SD 
10); Con 67 (SD 10)
HY = Exp 2.5 (SD 0.5); 
Con 2.5 (SD 0.7)
Exp =  PRE of knee leg press + usual care (light calisthenics 
and stretching, treadmill, cycle ergometer and lifting 
weights [machines and free weights] with the upper 
extremities)
  Progression: Each week 60–70% of the 1 Repetition 
Maximum weight (13 RPE; somewhat hard)
 XFFLÛXFFLTTFUTPGUPSFQFUJUJPOT
Con = Usual care group
Muscle strength
Knee E (isokinetic dynamometer, Nm)
Physical performance
6-min walk (m)
Stair ascent and descent (s)
Follow-up = 0, 12 weeks
Hirsch et al 
(2003)
RCT n = 13
Age (yr) = Exp 71 (SD 3); 
Con 76 (SD 2)
HY = Exp 1.8 (SD 0.3); 
Con 1.9 (SD 0.6)
Exp =  Balance training + PRE of ankle E, knee E, hip E 
(Equipment)
 Progression: 60–80% of 4 Repetition Maximum
 XFFLÛXFFLNJOTFUPGSFQFUJUJPOT
Con = Balance training, 30 min
Muscle strength
Knee E and F, ankle E (pulley system, kg)
Physical performance
Balance (EquiTest-SOT): Proportion of trials 
resulting in falls under balance conditions 4 to 6
Follow-up = 0, 10, 14 weeks
Schilling et 
al (2010)
Q-RCT n = 15 (9 male)
Age (yr) = Exp 61 (SD 9); 
Con 57 (SD 7)
HY = Exp 1.8 (SD 0.3); 
Con1.9 (SD 0.3)
Exp =  Leg press, seated leg curl, and calf press (Hammer 
Strength)
  Progression: 8 repetitions completed for 3 sets: 
weight B5–10%
 XFFLÛXFFLTTFUTPGUPSFQFUJUJPOT
Con = Usual care
Muscle strength
Knee E (leg press machine, kg)
Physical performance
6-min walk (m)
ABC (score)
TUG (s)
Follow-up = 0, 8 weeks
aOnly the groups related to the current study objectives are shown. RCT = randomised controlled trial; Q-RCT = quasi-randomised controlled trial; PRE = progressive resistance exercise; HY = 
Hoehn and Yahr; SOT = Sensory organisation test; Exp = experimental group; Con = control group; E = extensors; F= ﬂexors; SPPB = the Short Physical Performance Battery; ABC = Activities-
speciﬁc Balance Conﬁdence; TUG = Timed Up and Go test; PDQ-39 = Parkinson’s disease questionnaire
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2010, Hirsch et al 2003, Dibble et al 2006) and one long-term 
intervention of 6 months (Allen et al 2010a). Progressive 
resistance exercise training was carried out over 2–3 days/
week. In one trial, intensity was high at 60–80% of the 
4 Repetition Maximum with low (1 set of 12) repetitions 
(Hirsch et al 2003). Two trials used the perceived exertion 
rating to gradually increase the intensity from very, very 
light to hard or heavy (Allen et al 2010a, Dibble et al 2006). 
One trial set the intensity at the maximal effort carried out 
to volitional fatigue (Schilling et al 2010). Two trials used 
standard-care controls, ie, people engaged in an existing 
rehabilitation program appropriate for their disease and 
impairments, such as walking on a treadmill (Dibble et al 
2006) or balance training (Hirsch et al 2003). Participants 
in the control groups of the remaining trials were instructed 
to continue their standard care (Schilling et al 2010) or 
received usual care from their medical practitioner and 
community services (Allen et al 2010a).
Outcome measures: Strength was reported as a continuous 
measure of maximum voluntary force or torque production 
in three trials (Allen et al 2010a, Dibble et al 2006, Schilling 
et al 2010). The remaining trial only reported submaximal 
voluntary force as a strength outcome measure (Hirsch et 
al 2003).
Physical performance was measured in all four trials. One 
trial (Schilling et al 2010) used the Timed Up and Go Test, 
the Activities-speciﬁc Balance Conﬁdence scale, and the 
6-minute walk test. One trial (Hirsch et al 2003) used the 
EquiTest Score to measure balance. One trial (Dibble et al 
2006) measured physical performance using the 6-minute 
walk test and the time to ascend and descend stairs. The 
last trial (Allen et al 2010a) measured sit-to-stand time and 
walking velocity as separate physical performance outcome 
measures, along with the Short Physical Performance 
Battery, which incorporates tests of standing balance, sit-
to-stand time, and walking velocity. Table 2 summarises 
the included trials.
Effect of intervention
Strength: The effect of progressive resistance exercise 
on strength was examined by pooling post-intervention 
data from 3 trials involving 79 participants (Dibble et al 
2006, Allen et al 2010a, Schilling et al 2010). Progressive 
resistance exercise increased strength by a standardised 
Lima et al: Progressive resistance exercise in Parkinson’s disease
'JHVSF. SMD (95% CI) of effect of progressive 
resistance exercise on strength after 8–24 weeks of 
training by pooling data from 3 trials (n = 79).
Schilling 2010
Allen 2010a
Dibble 2006
Pooled
–1 0 1 2 3
Schilling 2010
Dibble 2006
Pooled
–100 0 100
m
300200 400
Figure 4. MD (95% CI) of effect of progressive resistance 
exercise on 6-minute walk test distance after 8–12 weeks 
of training by pooling data from 2 trials (n = 34).
5BCMF Effect of progressive resistance exercise on measures of physical performance.
Trial Duration of 
intervention 
(wk)
Outcome measure Difference between groups 
Exp minus Con
Mean difference 95% CI
Schilling et 
al (2010)
8 6-min walk test (m)
ABC Scale (0 worst to 100 best)
Timed Up and Go test (s)
93
6.7
–1.05
34 to 152
–8.5 to 21.9
–2.18 to 0.08
Hirsch et al 
(2003)
10 Balance (EquiTest score) 13 8 to 18
Dibble et al 
(2006)
12 Stair ascent (s)
Stair descent (s)
6-minute walk test (m)
–1.5
–1.0
122
–3.7 to 0.7
–3.0 to 1.0
–51 to 294
Allen et al 
(2010a)
24 Sit-to-stand time for 5 reps (s)
Fast walking speed (m/s)
Comfortable walking speed (m/s)
Short Physical Performance Battery
–1.9
0.13
–0.01
0.001
–3.62 to –0.18
–0.08 to 0.34
–0.16 to 0.14
–0.17 to 0.18
Exp = experimental group, Con = control group; ABC = The Activities-speciﬁc Balance Conﬁdence
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mean difference of 0.50 (95% CI 0.05 to 0.95, I2 = 0%), as 
presented in Figure 2. See Figure 3 on the eAddenda for 
the detailed forest plot. One trial (Hirsch et al 2003) could 
not be included in the pooled analysis because strength was 
measured as submaximal, not maximal, voluntary force.
Physical performance: The effect of progressive resistance 
exercise on the 6-minute walk test distance was examined 
by pooling post-intervention data from 2 trials (Dibble et al 
2006, Schilling et al 2010). Progressive resistance exercise 
improved walking capacity by 96 metres (95% CI 40 to 152, 
I2 = 0%) compared with control, as presented in Figure 4. See 
Figure 5 on the eAddenda for the detailed forest plot. Four 
included trials evaluated the effect of progressive resistance 
exercise on different physical performance outcomes, 
such as chair rise test and the Short Physical Performance 
Battery (Table 3). After short-term intervention, statistically 
non-signiﬁcant improvements occurred in the Timed Up 
and Go test (by 1 second), the Activities-speciﬁc Balance 
Conﬁdence scale (by 7 points), and stair ascent/descent 
time (by about 1 second). After long-term intervention, the 
Allen et al (2010) trial reported a statistically signiﬁcant 
improvement of 1.9 seconds in the sit-to-stand time. The 
other physical performance measures in that trial showed 
non-signiﬁcant improvements, with 0.13 m/s higher fast 
walking speed, 0.01 m/s lower comfortable walking speed, 
and 0.001 points higher on the Short Physical Performance 
Battery.
Discussion
This systematic review provides evidence that progressive 
resistance exercise can improve strength and several 
measures of functional ability as well in Parkinson’s disease. 
The results of this systematic review quantify the results of 
a recent narrative review suggesting positive effects from 
progressive resistance exercise for patients with Parkinson’s 
disease (David et al 2012). The mean PEDro score of 5 for 
the trials included in the current review represents moderate 
quality, suggesting that the ﬁndings are believable. This 
review shows that the implementation of progressive 
resistance exercise produced a positive and moderate effect 
size on strength in people with Parkinson’s disease (SMD = 
0.50). The reasonably consistent results across the trials may 
reﬂect that all trials administered progressive resistance 
exercise at an intensity and duration recommended by the 
ACSM (2002). The trials included in the current review 
averaged 15 weeks of progressive resistance exercise (range 
8 to 24), and the intensity measured by perceived exertion 
ratings of 13 (somewhat hard) (Dibble et al 2006) and 15 
(hard or heavy) (Allen et al 2010a) was adequate to produce 
a training effect. Ratings of perceived exertion of 13 and 
17 correspond to around 66% and 80% of the voluntary 
maximal force production, respectively (Borg et al 1970, 
Lagally and Amorose 2007). Therefore, the perceived 
exertion ratings of the included trials represented values 
within the intensity recommended by the American College 
of Sports Medicine (2002) guidelines for novices (60–70% 
of 1 Repetition Maximum). These results suggest that 
therapists should consider including progressive resistance 
exercise in exercise programs to increase strength in people 
with mild to moderate Parkinson’s disease.
Walking capacity is determined as the distance a person 
is capable of walking over a long period of time, typically 
for 6 minutes, as in the 6-minute walk test (Reybrouk 
2003). The progressive resistance exercise increased 
the 6-minute walk test distance by 96 metres. An 
improvement of 82 metres in the same test has been shown 
to be meaningful in people with Parkinsonism (Steffen 
and Seney 2008). However, one of the two trials included 
in this meta-analysis used progressive resistance exercise 
associated with exercises such as walking on a treadmill. 
Consequently, this intervention may have produced task-
speciﬁc training for gait, thereby increasing the measured 
effects of the progressive resistance exercise on the 
walking tests. Therefore, these results should be interpreted 
cautiously. Further research is required to determine if 
progressive resistance exercise programs alone can improve 
the 6-minute walking capacity in people with Parkinson’s 
disease. Although this result is encouraging, the effects of 
progressive resistance exercise on the physical performance 
of this population remain unclear.
Some measures of physical performance used in the trials 
showed non-signiﬁcant improvement, such as the 7% change 
in the Activities-speciﬁc Balance Conﬁdence scale and the 
3% change in walking speed. This minor improvement in 
physical performance may have been the result of the mild 
disability of the participants based on their average Hoehn 
and Yahr scores, which ranged from 1.8 to 2.5. These results 
are in line with the results of Buchner et al (1996), which 
suggested that small changes in physiological capacity could 
have substantial effects on performance in frail adults, while 
large changes in capacity have little or no effect in mild 
disability. This has been suggested in stroke patients (Ada 
et al 2006) and in children with cerebral palsy (Scianni et 
al 2009), and it may also be true in people with Parkinson’s 
disease. In the trial by Allen et al (2010b), muscle power 
was more strongly associated with walking velocity and 
falls than muscle strength in people with mild to moderate 
Parkinson’s disease. It is possible that it is not just the force 
of muscle contraction that determines the ability of people 
with Parkinson’s disease to perform physical activities; the 
muscle power may be another important contributor.
The results of this systematic review have suggested 
that progressive resistance exercise can be effective and 
worthwhile in people with mild to moderate Parkinson’s 
disease, but carryover of these beneﬁts may not occur in 
all measures of physical performance. We recommend that 
progressive resistance exercise should be implemented 
into clinical practice as a therapy for Parkinson’s disease, 
particularly when the aim is improving walking capacity in 
such people. Q
eAddenda: Appendix 1, Figure 3 and Figure 5 available at 
jop.physiotherapy.asn.au
Support: CNPq and FAPEMIG (Brazilian Government 
Funding Agencies), and Pro Reitoria de Pesquisa-UFMG 
(technical support in editing the manuscript).
Correspondence: Professor Fátima Rodrigues-de-Paula, 
Department of Physical Therapy, Universidade Federal de 
Minas Gerais, Brazil. Email: fatimarp@globo.com
Journal of Physiotherapy 2013  Vol. 59  –  © Australian Physiotherapy Association 2013 13
References
Ada L, Dorsch S, Canning CG (2006) Strengthening 
interventions increase strength and improve activity 
after stroke: a systematic review. Australian Journal of 
Physiotherapy 52: 241–248.
Allen NE, Canning CG, Sherrington C, Fung VSC (2009) 
Bradykinesia, muscle weakness and reduced muscle power 
in Parkinson’s disease. Movement Disorders 24: 1344–1351.
Allen NE, Canning CG, Sherrington C, Lord SR, Latt MD, Close 
JCT, et al (2010a) The effects of an exercise program on fall 
risk factors in people with Parkinson’s disease: a randomized 
controlled trial. Movement Disorders 25: 1217–1225.
Allen NE, Sherrington C, Canning CG, Fung VSC (2010b) 
Reduced muscle power is associated with slower walking 
velocity and falls in people with Parkinson’s disease. 
Parkinsonism and Related Disorders 16: 261–264.
American College of Sports Medicine (2002) Progression 
models in resistance training for healthy adults. Medicine 
and Science in Sports and Exercise 34: 364–380.
Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG (2006) 
Development and validation of MIX: comprehensive free 
software for meta-analysis of causal research data. BMC 
Medical Research Methodology 6: 50.
Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG (2008) MIX: 
comprehensive free software for meta-analysis of causal 
SFTFBSDIEBUB7FSTJPOIUUQNJYGPSNFUBBOBMZTJTJOGP
Borg G (1970) Perceived exertion as an indicator of somatic 
stress. Scandinavian Journal of Rehabilitation Medicine 2: 
92–98.
Buchner DM, Larson EB, Wagner EH, Koepsell TD, de Lateur 
BJ (1996) Evidence for a non-linear relationship between 
leg strength and gait speed. Age and Ageing 25: 386–391.
Cano-de-la-Cuerda R, Perez-de-Heredia M, Miangolarra-Page 
JC, Muñoz-Hellin E, Fernandez-de-las-Penas C (2010) Is 
there muscular weakness in Parkinson’s disease? American 
Journal of Physical Medicine & Rehabilitation 89: 70–76.
David FJ, Rafferty MR, Robichaud JA, Prodoehl J, Kohrt WM, 
Vaillancourt DE, et al (2012) Progressive resistance exercise 
and Parkinson’s disease: a review of potential mechanisms. 
Parkinson’s Disease EPJ
De Morton NA (2009) The PEDro scale is a valid measure of 
the methodological quality of clinical trials: a demographic 
study. Australian Journal of Physiotherapy 55: 129–133.
Dibble LE, Hale TF, Marcus RL, Droge J, Gerber JP, LaStayo 
PC (2006) High-intensity resistance training ampliﬁes 
muscle hypertrophy and functional gains in persons with 
Parkinson’s disease. Movement Disorders 21: 1444–1452.
Dibble LE, Hale TF, Marcus RL, Gerber JP, LaStayo PC (2009) 
High intensity eccentric resistance training decreases 
bradykinesia and improves quality of life in persons with 
Parkinson’s disease: a preliminary study. Parkinsonism and 
Related Disorders 15: 752–757.
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, 
Holloway RG, Kieburtz K, et al (2007) Projected number 
of people with Parkinson disease in the most populous 
nations, 2005 through 2030. Neurology 68: 384–386.
Falvo MJ, Schilling BK, Earhart GM (2008) Parkinson’s 
disease and resistive exercise: rationale, review and 
recommendations. Movement Disorders 23: 1–11.
Hirsch MA, Toole T, Maitland CG, Rider RA (2003) The effects 
of balance training and high-intensity resistance training 
on persons with idiopathic Parkinson’s disease. Archives of 
Physical Medicine & Rehabilitation 84: 1109–1117.
Inkster LM, Eng JJ, MacIntyre DL, Stoessl AJ (2003) Leg 
muscle strength is reduced in Parkinson’s disease and 
relates to the ability to rise from a chair. Movement Disorders 
18: 157–162.
Kaltenboeck A, Johnson SJ, Davis MR, Birnbaum HG, Carroll 
CA, Tarrants ML, Siderowf AD (2011) Direct costs and 
survival of Medicare beneﬁciaries with early and advanced 
Parkinson’s disease. Parkinsonism and Related Disorders 
18: 321-326.
Kwakkel G, de Goede CJT, van Wegen EEH (2007) Impact of 
physical therapy for Parkinson’s disease: a critical review 
of the literature. Parkinsonism and Related Disorders 13: 
S478–487.
Lagally KM, Amorose AJ (2007) The validity of using prior 
ratings of perceive exertion to regulate resistance exercise 
intensity. Perceptual and Motor Skills 104: 534–542.
Lang AE, Lozano AM (1998) Parkinson’s disease: second of 
two parts. New England Journal of Medicine 339: 1130–1143.
Latt MD, Lord SR, Morris JG, Fung VS (2009) Clinical and 
physiological assessments for elucidating falls risk in 
Parkinson’s disease. Movement Disorders 24: 1280–1289.
Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins 
M (2003) Reliability of the PEDro scale for rating quality of 
randomized controlled trials. Physical Therapy 83: 713–721.
Nallegowda M, Singh U, Handa G, Khanna M, Wadhwa S, 
Yadav SL, et al (2004) Role of sensory input and muscle 
strength in maintenance of balance, gait, and posture 
in Parkinson’s disease: a pilot study. American Journal of 
Physical Medicine & Rehabilitation 83: 898–908.
Pääsuke M, Ereline J, Gapeyeva H, Joost K, Mottus K, Taba P 
(2004) Leg-extension strength and chair-rise performance 
in elderly women with Parkinson’s disease. Journal of Aging 
and Physical Activity 12: 511–524.
Poewe W, Mahlknecht P (2009) The clinical progression of 
Parkinson’s disease. Parkinsonism and Related Disorders 
15S: S28–32.
Reybrouk T (2003) Clinical usefulness and limitations of 
the 6-minute walk test in patients with cardiovascular or 
pulmonary disease. Chest 123: 326.
Scianni A, Butler JM, Ada L, Teixeira-Salmela LF (2009) Muscle 
strengthening is not effective in children and adolescents 
with cerebral palsy: a systematic review. Australian Journal 
of Physiotherapy 55: 81–87.
Schilling BK, Pfeiffer RF, LeDoux MS, Karlage RE, Bloomer 
JR, Falvo MJ (2010) Effects of moderate-volume, high-load 
lower body resistance training on strength and function in 
persons with Parkinson’s disease: a pilot study. Parkinson’s 
Disease 2010: 1–6.
Steffen T, Seney M (2008) Test-retest reliability and minimal 
detectable change on balance and ambulation tests, the 
36-item short-form health survey, and the uniﬁed Parkinson 
disease rating scale in people with Parkinsonism. Physical 
Therapy 88: 733–746.
Weintraub D, Comella CL, Horn S (2008) Parkinson’s disease-
part 2: treatment of motor symptoms. The American Journal 
of Managed Care 14: S49–58.
Websites
www.pedro.org.au
www.meta-analysis-made-easy.com
Lima et al: Progressive resistance exercise in Parkinson’s disease
